| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0003-4975(99)00807-3 |
| P8608 | Fatcat ID | release_wjyjy6lfjrft5m6rt655tea2ma |
| P698 | PubMed publication ID | 10509970 |
| P2093 | author name string | Symes JF | |
| Isner JM | |||
| Losordo DW | |||
| Esakof DD | |||
| Vale PR | |||
| Lathi KG | |||
| Mayskiy M | |||
| P2860 | cites work | Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results | Q34068061 |
| Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model | Q34125421 | ||
| Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia | Q36827954 | ||
| Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb | Q39425647 | ||
| Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease | Q39462155 | ||
| Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion | Q45880288 | ||
| Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia | Q45886388 | ||
| Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia | Q45890406 | ||
| Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart | Q46137438 | ||
| Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results | Q47910562 | ||
| Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart | Q64382204 | ||
| VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts | Q71139703 | ||
| Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis | Q71563623 | ||
| Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs | Q71623264 | ||
| Therapeutic Angiogenesis | Q72074297 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| gene therapy | Q213901 | ||
| P304 | page(s) | 830-6; discussion 836-7 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | The Annals of Thoracic Surgery | Q1939819 |
| P1476 | title | Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease | |
| P478 | volume | 68 |
| Q31046533 | A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium |
| Q45869309 | Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction |
| Q44741128 | Adenovirus-mediated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs |
| Q35949680 | Angiogenic strategy for human ischemic heart disease: brief overview |
| Q30480151 | Angiomyogenesis for myocardial repair |
| Q44592507 | Arteriogenesis Induced by Intramyocardial Vascular Endothelial Growth Factor 165 Gene Transfer in Chronically Ischemic Pigs |
| Q35019038 | Basic principles of angiogenesis for the interventional cardiologist |
| Q35915765 | Cardiovascular gene delivery: The good road is awaiting |
| Q33838040 | Cardiovascular gene therapy |
| Q43621188 | Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure |
| Q44020269 | Catheter-based transendocardial myocardial gene transfer. |
| Q34582629 | Clinical applications of cardiovascular angiogenesis |
| Q34119449 | Clinical applications of vascular gene therapy |
| Q45878227 | Clinical efforts to modulate angiogenesis in the adult: gene therapy versus conventional approaches |
| Q35576409 | Clinical gene therapy for nonmalignant disease |
| Q43831854 | Critical appraisal of the mouse model of myocardial infarction |
| Q35561306 | Current Perspectives in Therapeutic Myocardial Angiogenesis |
| Q35949692 | Current clinical perspectives on myocardial angiogenesis. |
| Q35045765 | Designer blood vessels and therapeutic revascularization |
| Q73991331 | Differences in myocardial and peripheral VEGF and KDR levels after acute ischemia |
| Q44773869 | Distribution of Intramyocardially injected extracellular MR contrast medium: effects of concentration and volume |
| Q53294337 | Effect of mini-tyrosyl-tRNA synthetase/mini-tryptophanyl-tRNA synthetase on ischemic angiogenesis in rats: proliferation and migration of endothelial cells |
| Q39409566 | Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy. |
| Q81513976 | Effects of total coronary artery occlusion on vascular endothieial growth factor and transforming growth factor beta |
| Q40693358 | Electroporation in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle |
| Q37157213 | Exercise training and peripheral arterial disease |
| Q37284651 | Factors determining heterogeneity in coronary collateral development: A clinical perspective. |
| Q26769595 | Gene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and Perspectives |
| Q36675432 | Gene and cell therapy for chronic ischaemic heart disease |
| Q35218715 | Gene interventions in the beta-adrenergic system for treating heart failure |
| Q36617570 | Gene targeting in ischemic heart disease and failure: translational and clinical studies |
| Q37776515 | Gene therapy and angiogenesis in patients with coronary artery disease |
| Q35164797 | Gene therapy for cardiovascular angiogenesis |
| Q34319721 | Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb - on the way to the clinic |
| Q37310450 | Gene therapy to treat cardiovascular disease |
| Q35141791 | Gene transfer as a tool to induce therapeutic vascular growth |
| Q36304278 | Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end? |
| Q35937557 | Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia |
| Q34982950 | Gene transfer to the vasculature: historical perspective and implication for future research objectives |
| Q35218706 | Gene-based therapeutic angiogenesis |
| Q34482530 | Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb? |
| Q37061103 | Growth factors and cell therapy in myocardial regeneration |
| Q45857469 | HVJ-envelope vector for gene transfer into central nervous system |
| Q30758542 | Increased revascularization efficacy after administration of an adenovirus encoding VEGF(121). |
| Q28212065 | Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats |
| Q46181399 | Lentiviral gene delivery of vMIP-II to transplanted endothelial cells and endothelial progenitors is proangiogenic in vivo |
| Q40630019 | Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigs |
| Q36634798 | Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease |
| Q36108746 | MRI in guiding and assessing intramyocardial therapy. |
| Q51822938 | Mesenchymal stem cells genetically modified with the angiopoietin-1 gene enhanced arteriogenesis in a porcine model of chronic myocardial ischaemia. |
| Q36480080 | Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy |
| Q35856369 | Molecular imaging of cardiovascular gene products |
| Q34803109 | Molecular medicine for the cardiac surgeon |
| Q44098879 | Myocardial functional recovery after fibroblast growth factor 2 gene therapy as assessed by echocardiography and magnetic resonance imaging |
| Q34503413 | Myocardial gene therapy |
| Q34119456 | Myocardial gene transfer |
| Q35949615 | Nitric oxide signaling during myocardial angiogenesis |
| Q36226806 | Non-viral vectors for gene therapy: clinical trials in cardiovascular disease |
| Q36994178 | Nonviral vector gene modification of stem cells for myocardial repair |
| Q46070329 | One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients |
| Q38113171 | Percutaneous approaches for efficient cardiac gene delivery. |
| Q39941142 | Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct. |
| Q79767556 | Post-transcriptional modifications of VEGF-A mRNA in non-ischemic dilated cardiomyopathy |
| Q45870003 | Pre‐administration of angiopoietin‐1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model |
| Q35216565 | Pro: anesthesiologists' role in treating refractory angina: spinal cord stimulators, thoracic epidurals, therapeutic angiogenesis, and other emerging options |
| Q77309603 | Protein and angiogenic dose-response expression of phVEGF-A(165) gene in rat myocardium |
| Q35949666 | Protein-, gene-, and cell-based therapeutic angiogenesis for the treatment of myocardial ischemia |
| Q30487688 | Quantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardium |
| Q37085665 | Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium |
| Q36081298 | Reappraisal of recent clinical trials of angiogenic therapy in myocardial ischemia |
| Q35070251 | Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease |
| Q30946248 | Role of single photon emission computed tomography imaging in the evaluation of therapy for angina pectoris |
| Q45881622 | Simultaneous surgical revascularization and angiogenic gene therapy in diffuse coronary artery disease |
| Q34324856 | Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease |
| Q33264719 | Spinal cord stimulation: a comparison of efficacy versus other novel treatments for refractory angina pectoris |
| Q33509006 | Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model |
| Q36379360 | Targeting vascular endothelial growth factor in angina therapy |
| Q37008834 | Targets for regulating angiogenesis in the ageing endothelium |
| Q35799722 | The evolution of heart gene delivery vectors |
| Q73999697 | The feasibility and safety of fluoroscopy-guided percutaneous intramyocardial gene injection in porcine heart |
| Q34317814 | The future of human gene therapy |
| Q36596455 | The future of therapeutic myocardial angiogenesis |
| Q35065245 | The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. |
| Q35777375 | Therapeutic angiogenesis for myocardial ischemia |
| Q34675242 | Therapeutic angiogenesis in critical limb and myocardial ischemia |
| Q33223678 | Therapeutic angiogenesis induced by injecting hepatocyte growth factor in ischemic canine hearts |
| Q35814821 | Therapeutic angiogenesis using vascular endothelial growth factor |
| Q36976439 | Therapeutic myocardial angiogenesis |
| Q35949638 | Therapeutic myocardial angiogenesis with vascular endothelial growth factors |
| Q30786866 | Three-dimensional study of the capillary supply of skeletal muscle fibres using confocal microscopy |
| Q39926866 | Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction |
| Q35101166 | Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis |
| Q73229124 | Transmyocardial laser revascularization |
| Q31112721 | Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation |
| Q37720734 | VEGF 165 gene therapy for patients with refractory angina: mobilization of endothelial progenitor cells |
| Q34635640 | VEGF gene delivery for treatment of ischemic cardiovascular disease |
| Q28260984 | VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond |
| Q73033342 | VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease |
| Q38121727 | Vascular endothelial growth factor in heart failure |
| Q43920993 | Vascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary artery |
| Q34481171 | Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis |
| Q35073986 | Vascular growth factors and angiogenesis in cardiac surgery. |
| Q30489689 | Virus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand? |
| Q74601191 | [Growth factors for therapeutic angiogenesis in cardiovascular diseases] |
Search more.